800634991	800634991	CD	B-NP	O
|	|	NN	I-NP	O
MH	MH	NN	I-NP	O
|	|	NN	I-NP	O
56611655	56611655	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
443029	443029	CD	B-NP	O
|	|	CC	I-NP	O
4/7/2002	4/7/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
chf	chf	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/27/2002	6/27/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/9/2002	1/9/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
ORSZULAK	ORSZULAK	NN	B-NP	O
,	,	,	O	O
LEN	LEN	NN	B-NP	O
B	B	NN	I-NP	O
963-31-04-5	963-31-04-5	CD	I-NP	O
S	S	NNP	I-NP	O
An	An	NNP	I-NP	O
Erna	Erna	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/23/02	1/23/02	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KAMINSKY	KAMINSKY	NNP	B-NP	O
,	,	,	O	O
LYNN	LYNN	NNP	B-NP	O
GARFIELD	GARFIELD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/9/02	10/9/02	CD	B-NP	O
by	by	IN	B-PP	O
FABERT	FABERT	NNP	B-NP	O
,	,	,	O	O
CARSON	CARSON	NNP	B-NP	O
DOMINGO	DOMINGO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
3	3	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
27984690	27984690	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/02	5/27/02	CD	B-NP	O
by	by	IN	B-PP	O
OXFORD	OXFORD	NNP	B-NP	O
,	,	,	O	O
ELDRIDGE	ELDRIDGE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
watch	watch	VB	I-VP	O
WELLBUTRIN	WELLBUTRIN	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
BUPROPION	BUPROPION	NN	I-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
B12	B12	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
400	400	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
FOLATE	FOLATE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	VBP	B-VP	O
on	on	IN	B-PP	O
9/29	9/29	CD	B-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PYRIDOXINE	PYRIDOXINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
COUMADIN	COUMADIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NN	I-NP	O
tonight	tonight	NN	I-NP	O
;	;	:	O	O
4	4	CD	B-NP	O
MG	MG	NN	I-NP	O
qhs	qh	NNS	I-NP	O
PO	PO	NN	I-NP	B-protein
QD	QD	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
tonight	tonight	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
qhs	qh	NNS	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
8/30	8/30	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
tonight	tonight	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	O	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
starting	start	VBG	B-VP	O
tomorrow	tomorrow	NN	B-NP	O
night	night	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/9/02	10/9/02	CD	B-NP	O
by	by	IN	B-PP	O
MASTEL	MASTEL	NNP	B-NP	O
,	,	,	O	O
ROSS	ROSS	NNP	B-NP	O
ERVIN	ERVIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
reason	reason	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/02	5/27/02	CD	B-NP	O
by	by	IN	B-PP	O
JANECZEK	JANECZEK	NNP	B-NP	O
,	,	,	O	O
BART	BART	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ASA	ASA	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
04697348	04697348	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
watch	watch	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/02	5/27/02	CD	B-NP	O
by	by	IN	B-PP	O
GORN	GORN	NNP	B-NP	O
,	,	,	O	O
LENNY	LENNY	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
watch	watch	VB	I-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

RAMIPRIL	RAMIPRIL	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
COZAAR	COZAAR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
PREMPRO	PREMPRO	NN	I-NP	O
0.625	0.625	CD	B-NP	O
MG/2	MG/2	NN	I-NP	O
.5	.5	CD	B-NP	O
MG	MG	NN	I-NP	O
1	1	CD	B-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/23/02	1/23/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
following	follow	VBG	B-PP	O
PRILOSEC	PRILOSEC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/23/02	1/23/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
&	&	CC	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
following	follow	VBG	B-PP	O
RETURN	RETURN	NNP	B-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
IN	IN	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
DAYS	DAYS	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Brakeman	Brakeman	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
wks	wk	NNS	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
IDDM	IDDM	NN	I-NP	O
HTN	HTN	NN	I-NP	O
CAD.S	CAD.S	NN	I-NP	O
/	/	SYM	B-NP	O
P	P	NN	I-NP	O
IMI	IMI	NN	I-NP	O
1986	1986	CD	I-NP	O
PERIPHERAL	PERIPHERAL	NNP	I-NP	O
NEUROPATHY	NEUROPATHY	NNP	I-NP	O
RETINOPATHY	RETINOPATHY	NNP	I-NP	O
NEPHROPATHY	NEPHROPATHY	NNP	I-NP	O
Mild	Mild	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
with	with	IN	B-PP	O
?	?	.	O	O

pneumonia	pneumonia	NN	B-NP	O
mitral	mitral	JJ	I-NP	O
insuff	insuff	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
mitral	mitral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cva	cva	NN	I-NP	O
10/12	10/12	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
55	55	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
10/12	10/12	CD	I-NP	O
,	,	,	O	O
CRF	CRF	NN	B-NP	B-protein
,	,	,	O	O
admitted	admit	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
5	5	CD	B-NP	O
lb	lb	NN	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
and	and	CC	I-NP	O
orthopnea/PND	orthopnea/PND	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
flares	flare	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
every	every	DT	I-NP	O
6	6	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
130-135	130-135	CD	B-NP	O
lbs	lb	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
follows	follow	VBZ	B-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Baseline	Baseline	NN	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
is	be	VBZ	B-VP	O
5	5	CD	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
increased	increase	VBN	B-NP	O
weight	weight	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
lb/d	lb/d	NN	I-NP	O
x	x	SYM	B-NP	O
5d	5d	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
,	,	,	O	O
slight	slight	JJ	B-NP	O
incr	incr	NN	I-NP	O
.	.	.	O	O

SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
some	some	DT	B-NP	O
presacral	presacral	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
night	night	NN	B-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
awoke	awake	VBD	B-VP	O
from	from	IN	B-PP	O
sleep	sleep	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
sleep	sleep	VB	I-VP	O
sitting	sit	VBG	I-VP	O
upright	upright	RB	B-ADVP	O
for	for	IN	B-PP	O
remainder	remainder	NN	B-NP	O
of	of	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clear	clear	JJ	I-NP	O
dietary	dietary	JJ	I-NP	O
indiscretion	indiscretion	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
immediately	immediately	RB	I-NP	O
recent	recent	JJ	I-NP	O
med	me	VBN	I-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
ARB	ARB	NN	B-NP	B-protein
since	since	IN	B-PP	O
stroke	stroke	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
BP	BP	NN	B-NP	O
higher	high	JJR	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
afebrile	afebrile	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
12	12	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
wet	wet	JJ	B-NP	O
1/2	1/2	CD	I-NP	O
way	way	NN	I-NP	O
up	up	IN	B-PP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
dullness	dullness	NN	I-NP	O
at	at	IN	B-PP	O
both	both	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
,	,	,	O	O
TnI	TnI	NN	B-NP	B-protein
negative	negative	JJ	I-NP	I-protein
x	x	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
;	;	:	O	O
TSH	TSH	NN	B-NP	O
normal	normal	JJ	B-ADJP	O
;	;	:	O	O
Labs	Lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
HCt	HCt	NN	B-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
baseline	baseline	NN	B-NP	O
=	=	SYM	B-VP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-NP	O
1L	1L	NN	I-NP	O
over	over	IN	B-PP	O
first	first	JJ	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
goal	goal	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
1-2L	1-2L	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Added	Add	VBN	B-VP	O
back	back	RB	B-ADVP	O
ARB	ARB	NN	B-NP	O
7/24	7/24	CD	I-NP	O
and	and	CC	O	O
plan	plan	VBP	B-VP	O
to	to	TO	I-VP	O
discharge	discharge	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
slightly	slightly	RB	B-NP	O
higher	high	JJR	I-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
until	until	IN	B-PP	O
weight	weight	NN	B-VP	O
down	down	RP	B-PRT	O
to	to	TO	B-VP	O
~	~	VB	I-VP	O
130lbs	130lb	NNS	B-NP	B-protein
.	.	.	O	O

Check	Check	NNP	B-NP	O
INR	INR	NNP	I-NP	O
Wed	Wed	VBD	B-VP	O
3/3	3/3	CD	B-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
2-3	2-3	NN	I-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Ellenbogen	Ellenbogen	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
draw	draw	NN	I-NP	O
for	for	IN	B-PP	O
INR	INR	NNP	B-NP	O
check	check	NN	I-NP	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
call	call	NN	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bayes	Bayes	NNP	I-NP	O
for	for	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
adjustment	adjustment	NN	I-NP	O
.	.	.	O	O

Follow	Follow	JJ	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	O
check	check	NN	I-NP	O
3/3	3/3	CD	I-NP	O
Follow	Follow	NNP	I-NP	O
weights	weight	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LEEMASTER	LEEMASTER	NN	B-NP	O
,	,	,	O	O
LLOYD	LLOYD	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HF86	HF86	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/23/02	1/23/02	CD	I-NP	O
@	@	IN	B-NP	O
10	10	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

